Skip to content

Depression research published in 2018

Page 5 of 10: studies 81 to 100 of 186, newest first. Back to the depression overview

Studies

Emotionally aligned: Preliminary results on the effects of a mindfulness‐based intervention for depression on congruence between implicit and explicit mood

Clinical Psychology & Psychotherapy July 18, 2018 Carina Remmers, Johannes Zimmermann, Alice E. Buxton et al. 10 citations

BACKGROUND: Mindfulness-based interventions (MBIs) are effective in treating major depression. Because mindfulness involves monitoring and accepting current experiences, it may lead people resolve incongruencies between emotional responses that would otherwise remain unnoticed. Mindfulness may thus foster congruence between implicit and explicit emotions. The current randomized controlled trial...

Does the association between mindful parenting and adolescents' dispositional mindfulness depend on the levels of anxiety and depression symptomatology in mothers?

Journal des adolescens July 13, 2018 Helena Moreira, Maria C Canavarro

The current study aims to investigate whether mindful parenting and adolescents' dispositional mindfulness differ as a function of maternal anxiety and depressive symptoms and to explore the moderating role of these symptoms on the relationship between mindful parenting and adolescents' dispositional mindfulness. A sample of 685 mother-adolescent dyads was collected in Portuguese public...

Ketamine differentially restores diverse alterations of neuroligins in brain regions in a rat model of neuropathic pain-induced depression.

Neuroreport July 4, 2018 Wei Pan, Guang-Fen Zhang, Hui-Hui Li et al.

Depression is present in a large proportion of patients suffering from chronic pain, and yet the underlying mechanisms remain to be elucidated. Neuroligins (NLs), as a family of cell-adhesion proteins, are involved in synaptic formation and have been linked to various neuropsychiatric disorders. Here, we studied the alterations in NL1 and NL2 in the medial prefrontal cortex (mPFC), the anterior...

Long‐term improvements after mindfulness‐based group therapy of depression, anxiety and stress and adjustment disorders: A randomized controlled trial

Early Intervention in Psychiatry July 3, 2018 Jan Sundquist, Karolina Palmér, Ashfaque A. Memon et al.

Although mindfulness‐based group therapies (MGTs) for depressive, anxiety or stress and adjustment disorders are promising, there is a substantial lack of knowledge regarding the long‐term improvements after such therapies in these common psychiatric disorders.

Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.

Molecular Psychiatry July 2018 B Kadriu, P W Gold, D A Luckenbaugh et al.

Patients with major depressive disorder (MDD) have clinically relevant, significant decreases in bone mineral density (BMD). We sought to determine if predictive markers of bone inflammation-the osteoprotegerin (OPG)-RANK-RANKL system or osteopontin (OPN)-play a role in the bone abnormalities associated with MDD and, if so, whether ketamine treatment corrected the abnormalities. The...

The impact of sex as a biological variable in the search for novel antidepressants.

Frontiers in neuroendocrinology July 2018 Alexia V Williams, Brian C Trainor

A roadblock to successful treatment for anxiety and depression is the high proportion of individuals that do not respond to existing treatments. Different underlying neurobiological mechanisms may drive similar symptoms, so a more personalized approach to treatment could be more successful. There is increasing evidence that sex is an important biological variable modulating efficacy of...

Loving Kindness Meditation zur Behandlung der chronischen Depression

Zeitschrift für Klinische Psychologie und Psychotherapie July 1, 2018 Viola N. L. S. Schilling, W. Lutz, Stefan G Hofmann et al.

Zusammenfassung. Theoretischer Hintergrund: Chronische Depressionen gehen mit einer langwierigen Belastung einher und verursachen hohe Krankheitskosten. Ein möglicher Ansatz zur Behandlung könnte die Loving Kindness Meditation (LKM) sein. Methode: In dieser Pilot-Studie wurde ein LKM-Gruppenprogramm eingesetzt und bezüglich der Effektivität untersucht. N = 2207 Fälle aus Wartelistendaten wurden...

Is Ketamine the Future Clozapine for Depression? A Case Series and Literature Review on Maintenance Ketamine in Treatment-resistant Depression With Suicidal Behavior.

Journal of Psychiatric Practice July 1, 2018 Lai Fong Chan, Choon Leng Eu, Shean Yih Soh et al. 18 citations

Ketamine has shown effectiveness as a rapid-acting antidepressant with antisuicidal effects in terms of reduction of suicidal ideation in the short term. However, the evidence for long-term maintenance ketamine therapy for treatment-resistant depression (TRD) and suicidal behavior is limited. This case series (N=13) highlights the role of adjunctive serial maintenance ketamine infusions in...

Mindfulness based interventions for depression and anxiety in Asian Population: A systematic review

Journal of Psychiatrists Association of Nepal June 28, 2018 Samjhana Thapaliya, K. D. Upadhyaya, Rohan Borschmann et al. 9 citations

Introduction: Mindfulness based interventions (MBIs) have emerged as effective interventions for various psychiatric conditions including depression and anxiety. Asia being home to Buddhist tradition, it will be interesting to explore the trend and efficacy of MBIs in Asian population in Asian settings. The aim of this study is to perform a systematic review of mindfulness based interventions...

Online mindfulness-enhanced cognitive behavioural therapy for anxiety and depression: Outcomes of a pilot trial

Internet Interventions June 22, 2018 Natalie Kladnitski, Jessica Simons Smith, Adrian R. Allen et al. 31 citations

Transdiagnostic internet-delivered cognitive behavioural therapies (iCBT) are effective for treating anxiety and depression, but there is room for improvement. In this study we developed a new Mindfulness-Enhanced iCBT intervention by incorporating formal and informal mindfulness exercises within an existing transdiagnostic iCBT program for mixed depression and anxiety. We examined the...

Effects of Mindfulness-Based Stress Reduction on Depression in Adolescents and Young Adults: A Systematic Review and Meta-Analysis

Frontiers in Psychology June 21, 2018 Xinli Chi, Ai Bo, Tingting Liu et al.

Background: Mindfulness as a positive mental health intervention approach has been increasingly applied to address depression in young people. This systematic review and meta-analysis evaluated the effects of mindfulness-based stress reduction (MBSR) in the treatment of depression among adolescents and young adults.Methods: Electronic databases and references in articles were searched....

DOI: 10.3389/fpsyg.2018.01034 (opens in new tab) Full text (opens in new tab) Mindfulness-based stress reduction Adolescents Young adults Randomized controlled trials +2

The Relevance of Explanatory First-Person Approaches (EFPA) for Understanding Psychopathological Phenomena. The Role of Phenomenology.

Frontiers in Psychology June 20, 2018 Philipp Schmidt

The main aim of this paper is to demonstrate the contributions of phenomenology-inspired approaches to the explanation of psychopathological phenomena. First, I introduce the notion of Explanatory First-Person Approaches (EFPA) which share the assumption that the explanation of consciousness and conscious phenomena necessitates, at least partially, phenomenal facts functioning as explanans....

Time until relapse after augmentation with single‐dose ketamine in treatment‐resistant depression

Psychiatry and Clinical Neurosciences June 19, 2018 R. Pérez-Esparza, T. Corona, R. Ruiz-García et al.

Growing evidence of the rapid antidepressant effects of ketamine represents a promising advance in treatment-resistant depression (TRD) therapeutics. Most studies provide information after treatment washout, reporting response up to 7 days and remission up to 3-5 days after a single dose.

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

Psychological Medicine June 15, 2018 Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias et al. 827 citations

Abstract Background Recent open-label trials show that psychedelics, such as ayahuasca, hold promise as fast-onset antidepressants in treatment-resistant depression. Methods To test the antidepressant effects of ayahuasca, we conducted a parallel-arm, double-blind randomized placebo-controlled trial in 29 patients with treatment-resistant depression. Patients received a single dose of either...

Overcoming Depression by Inhibition of Neural Burst Firing.

Neuron June 6, 2018 Daesoo Kim, Eunji Cheong, Hee-Sup Shin

The N-methyl-D-aspartate receptor (NMDAR) antagonist ketamine has been found to have rapid and long-lasting antidepressive effects. Two elegant studies from Hailan Hu's laboratory (Cui et al., 2018; Yang et al., 2018) showed that ketamine blocks burst firing of neurons in the lateral habenula (LHb), rapidly relieving symptoms of depression.

Dispositional mindfulness moderates the relationship between depression and posttraumatic growth in Chinese adolescents following a tornado

Personality and Individual Differences June 1, 2018 Wei Xu, Xu Ding, P. Goh et al.

Abstract This study explored whether dispositional mindfulness moderated the relationship between depression and posttraumatic growth. A total of 435 Chinese adolescents who experienced a tornado in Yancheng city reported their level of depressive symptoms (The Center for Epidemiologic Studies Depression Scale for Children; CES-DC), posttraumatic growth (Posttraumatic Growth Inventory; PTGI)...

Mindfulness-based cognitive therapy in patients with depression: current perspectives

Neuropsychiatric Disease and Treatment June 1, 2018 Meagan B. MacKenzie, Kayleigh A. Abbott, Nancy L. Kocovski 69 citations

Mindfulness-based cognitive therapy (MBCT) was developed to prevent relapse in individuals with depressive disorders. This widely used intervention has garnered considerable attention and a comprehensive review of current trends is warranted. As such, this review provides an overview of efficacy, mechanisms of action, and concludes with a discussion of dissemination. Results provided strong...

Addictive potential of novel treatments for refractory depression and anxiety

Neuropsychiatric Disease and Treatment June 1, 2018 Dušan Kolar 38 citations

Treatment-resistant mood disorders and anxiety disorders require intensive treatment, but treatment options should balance benefits and adverse effects or other potential detrimental effects on patients, including the risk of developing prescription medication addiction. Some of the newer treatment modalities for mood and anxiety disorders may have similar properties to benzodiazepines. The...

Identifying Ketamine Responses in Treatment-Resistant Depression Using a Wearable Forehead EEG

arXiv Preprint Archive May 29, 2018 Zehong Cao, Chin-Teng Lin, Weiping Ding et al. preprint

This study explores the responses to ketamine in patients with treatment-resistant depression (TRD) using a wearable forehead electroencephalography (EEG) device. We recruited fifty-five outpatients with TRD who were randomised into three approximately equal-sized groups (A: 0.5 mg/kg ketamine; B: 0.2 mg/kg ketamine; and C: normal saline) under double-blind conditions. The ketamine responses...

Full text (opens in new tab) Eess.sp Biomedical-sensors Depression-treatment Brain-wave-analysis +1

Depression and Psychosis- Perspectives on the Body, Enactivism, and Psychotherapy

University Library Heidelberg May 28, 2018 Adrian Spremberg 2 citations

This article will discuss how the ‘enactive’ approach to cognition and psychological processes can help further clarifying and developing a more heuristic framework for the understanding of severe mental disorders, in this case, depression and schizophrenia. Furthermore, enactivismwill serve as a framework that comprehends depressions and schizophrenia as disorders that encompass three...